The top-altered proteins in our study include VPS13C, ADIPOQ, and IGKV1D-13 which can be used as biomarkers for obesity-related IR and to identify individuals with a future risk for T2D. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.